share_log

Ainos and Tah-An Sign MoU To Explore Manufacture Of VELDONA Animal Investigational New Drug

Ainos and Tah-An Sign MoU To Explore Manufacture Of VELDONA Animal Investigational New Drug

愛諾斯與塔安簽署諒解備忘錄探討 VELDONA 動物研究新藥的製造
Benzinga Real-time News ·  2023/01/23 07:12

Ainos advances commercialization of its VELDONA low-dose interferon treatment through strategic partnerships

Ainos 通過戰略合作夥伴關係促進其 VELDONA 低劑量干擾素治療的商業化

Ainos intends to begin clinical trials into VELDONA's potential veterinary applications in the first quarter of 2023

艾諾斯打算在 2023 年第一季度開始對 VELDONA 潛在的獸醫應用進行臨床試驗

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論